Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease Patients
Clinical trial NCT02615847 · COMPLETED
Trial details
- NCT number
- NCT02615847
- Sponsor
- University of Zurich
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-03-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.